# HL-300 Ointment in Healthy Volunteers

> **NCT07684937** · PHASE1 · COMPLETED · sponsor: **Hangzhou Highlightll Pharmaceutical Co., Ltd** · enrollment: 36 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** HL-300
- **DRUG:** HL-300
- **DRUG:** HL-300
- **DRUG:** HL-300

## Key facts

- **NCT ID:** NCT07684937
- **Lead sponsor:** Hangzhou Highlightll Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-14
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07684937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07684937, "HL-300 Ointment in Healthy Volunteers". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07684937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*